3-hydroxy-2-quinoxalinepropionic acid has been researched along with 2,3-dihydroxyquinoxaline in 2 studies
| Studies (3-hydroxy-2-quinoxalinepropionic acid) | Trials (3-hydroxy-2-quinoxalinepropionic acid) | Recent Studies (post-2010) (3-hydroxy-2-quinoxalinepropionic acid) | Studies (2,3-dihydroxyquinoxaline) | Trials (2,3-dihydroxyquinoxaline) | Recent Studies (post-2010) (2,3-dihydroxyquinoxaline) |
|---|---|---|---|---|---|
| 8 | 0 | 5 | 25 | 0 | 9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Estrin, DA; Fabian, L; Martini, MF; Moglioni, AG; Sarduy, ES | 1 |
| Estrin, D; Fabian, L; Gómez, N; Moglioni, A; Salvatori, M; Taverna Porro, M; Turk, G | 1 |
2 other study(ies) available for 3-hydroxy-2-quinoxalinepropionic acid and 2,3-dihydroxyquinoxaline
| Article | Year |
|---|---|
Evaluation of quinoxaline compounds as ligands of a site adjacent to S2 (AS2) of cruzain.
Topics: Cysteine Endopeptidases; Drug Design; Humans; Ligands; Protozoan Proteins; Quinoxalines | 2019 |
Design, synthesis and biological evaluation of quinoxaline compounds as anti-HIV agents targeting reverse transcriptase enzyme.
Topics: Anti-HIV Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Structure; Quinoxalines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2020 |